medical

Dr. Dov Rand & His Amazing Work

anti aging, medical
Dr. Dov Rand:   Dr. Dov Rand is a doctor who specializes in medicine as well as rehabilitation for patients. This type of medical study has slowly started to become more popular over the years and Dr. Dov Rand has been able to learn so much of this area to show others the importance that it has on everyone. He attended the prestigious school called Albert Einstein Medical Center in New York. This is where he learned the majority of skills that he would be using through out his medical career. His hard work and determination through out the years encouraged him to open up his own practice. He has always been passionate about helping others and wanted to do so in his own business. He started his own practice in New Jersey, and his business is called Healthy Aging Medical Centers. ...

Jorge Moll: How Does the Brain Process humane such humane acts as selflessness

bioscience, medical
In one of his quests of understanding human nature and why people do what they do, Neurologist Jorge Moll, embarked on a study to identify how different humane acts impacts the brain. The study was informed by the fact that doing good often makes a person feel good. He, however, sought to understand how such good actions as donating money helping the needy, showing affection and attention to others as well as how any other considered ‘good deed’ impacted the doer’s brain. Jorge sought the assistance of fellow researcher and psychologist Joao Ascenso, in a study conducted at the D'Or Institute for Research and Education.   Findings   Through Functional Magnetic Resonance Imaging (fMRI), Jorge and his partner found out that these humane acts activated the Subgenual Cort

JEFF ARONIN, A PHARMACEUTICAL EXPERT

bioscience, Finance, medical
Jeff Aronin studied at the University of Northern Illinois BA degree and MBA from the University DePaul; Jeff Aronin worked in Medical health institution before becoming the Chief Executive Officer of Ovation Pharmaceuticals LLC. The Institution was established in the year 2000 when Jeff Aronin felt the need to help out patients with neglected therapeutic needs, particularly the individuals who had strange diseases. By making an engaged organization that was tending to one particular need, Jeff Aronin decided to invest all his assets towards one shared objective. This concentration on patients and drug advancement separated his organizations from others in the biotech that were more intrigued by finding the next blockbuster than dealing with the common diseases.   Jeff Aronin ha...